Pages that link to "Q47623830"

The following pages link to Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24. (Q47623830):

Displaying 29 items.

• Intraoperative radiation therapy (IORT) in head and neck cancer: A systematic review (Q30240034) (← links)
• Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer (Q33843578) (← links)
• Organ preservation trials for laryngeal cancer (Q35066525) (← links)
• Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data. (Q36378279) (← links)
• Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx (Q37399008) (← links)
• Pharmacotherapy of head and neck squamous cell carcinoma (Q37575538) (← links)
• Unknown primary cancer of the head and neck: a multidisciplinary approach. (Q37842965) (← links)
• Surgical margins in head and neck cancer: a contemporary review. (Q38040023) (← links)
• Microvascular reconstruction after intra-arterial chemotherapy with concomitant radiation (Q38124853) (← links)
• The importance of margins in head and neck cancer (Q38767185) (← links)
• Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue (Q40671192) (← links)
• Adjuvant chemoradiation for gastric cancer with infusional 5-fluorouracil and cisplatin: a phase I study (Q42606144) (← links)
• Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck (Q43266642) (← links)
• Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck. (Q43447566) (← links)
• Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer (Q44420696) (← links)
• Long-term follow-up on an intensified treatment regimen for advanced resectable head and neck squamous cell carcinomas (Q44450456) (← links)
• Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx (Q44853850) (← links)
• Treatment of base of tongue cancer, stage III and stage IV with primary surgery: survival and functional outcomes (Q45247304) (← links)
• Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer (Q48028979) (← links)
• AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma. (Q48240243) (← links)
• Comparisons of the clinical outcomes of different postoperative radiation strategies for treatment of head and neck squamous cell carcinoma (Q48630028) (← links)
• Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck. (Q53149355) (← links)
• Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma. (Q53407680) (← links)
• Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma. (Q54237862) (← links)
• Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC) (Q60046967) (← links)
• Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy (Q64079175) (← links)
• STAT1 activation in squamous cell cancer of the oral cavity: a potential predictive marker of response to adjuvant chemotherapy (Q80455307) (← links)
• Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer (Q80686769) (← links)
• Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria (Q100959508) (← links)